Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,451.40    19.80 (1.38%)
Bid:
1,454.00
Ask:
1,454.60
Spread: 0.60 (0.041%)
Market Cap: £248.89b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Transaction in Own Shares

1 Apr 2025 17:52

RNS Number : 2291D
HSBC Holdings PLC
01 April 2025
 

HSBC HOLDINGS PLC

1 April 2025

Transaction in own shares

 

HSBC Holdings plc ("HSBC" or the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of US$0.50 from Merrill Lynch International ("Merrill Lynch") as part of its buy-back announced on 20 February 2025.

UK Venues

Date of purchase:

1 April 2025

Number of ordinary shares of US$0.50 each purchased:

1,947,112

Highest price paid per share:

£8.8940

Lowest price paid per share:

£8.7070 

Volume weighted average price paid per share:

£8.8091

 

All repurchases on the London Stock Exchange, Cboe Europe Limited (through the BXE and CXE order books) and/or Turquoise ("UK Venues") are implemented as "on Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and as "market purchases" for the purposes of the Companies Act 2006.

Hong Kong Stock Exchange

Date of purchase:

1 April 2025

Number of ordinary shares of US$0.50 each purchased:

1,600,000 

Highest price paid per share:

HK$89.1000 

Lowest price paid per share:

HK$88.1500 

Volume weighted average price paid per share:

HK$88.5816 

All repurchases on The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") are "off market" for the purposes of the Companies Act 2006 but are transactions which occur "on Exchange" for the purposes of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and which constitute an "on-market share buy-back" for the purposes of the Codes on Takeovers and Mergers and Share Buy-backs.

Since the commencement of the buy-back announced on 20 February 2025, the Company has repurchased 139,503,496 ordinary shares for a total consideration of approximately US$1,589.3m.

On 1 April 2025, 29,628,800 of the ordinary shares of US$0.50 each which were awaiting cancellation having been repurchased on the Hong Kong Stock Exchange previously were cancelled. Following cancellation of those shares and following the cancellation of shares repurchased on the UK Venues, the Company's issued ordinary share capital will consist of 17,713,194,695 ordinary shares with voting rights. There are no ordinary shares held in treasury. Cancellation of the shares repurchased today on the Hong Kong Stock Exchange takes longer than those repurchased on the UK Venues and a further announcement of total voting rights will be made once those shares have been cancelled.

The above figure of 17,713,194,695 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Merrill Lynch on behalf of the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/2291D_1-2025-4-1.pdf

This announcement will also be available on HSBC's website at www.hsbc.com/sea

Enquiries to:

 

Lee DavisCorporate Governance & Secretariat

shareholderquestions@hsbc.com

+44 (0)20 7991 8888

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSPKDBNABKDBQK
Date   Source Headline
8th Apr 20246:10 pmRNSTransaction in Own Shares
5th Apr 202410:00 amRNSDirector Declaration
4th Apr 20246:24 pmRNSTransaction in Own Shares
3rd Apr 20246:14 pmRNSTransaction in Own Shares
2nd Apr 20245:59 pmRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSCompletion of the sale of HSBC Bank Canada to RBC
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:30 pmRNSDirector/PDMR Shareholding
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20245:58 pmRNSTransaction in Own Shares
27th Mar 20243:45 pmRNSPublication of base prospectus
26th Mar 20245:54 pmRNSTransaction in Own Shares
25th Mar 20245:58 pmRNSTransaction in Own Shares
22nd Mar 20245:50 pmRNSTransaction in Own Shares
22nd Mar 20242:00 pmRNSIssuance of subordinated unsecured notes
22nd Mar 202410:00 amRNS2024 AGM - Documents available at NSM
21st Mar 20246:03 pmRNSTransaction in Own Shares
21st Mar 202411:00 amRNSIssuance of subordinated unsecured notes
20th Mar 20245:51 pmRNSTransaction in Own Shares
20th Mar 202410:00 amRNSHong Kong Waiver-Contingent Convertible Securities
19th Mar 20245:46 pmRNSTransaction in Own Shares
19th Mar 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
18th Mar 20245:54 pmRNSTransaction in Own Shares
18th Mar 202411:20 amRNSPre Stabilisation Notice
15th Mar 20246:20 pmRNSTransaction in Own Shares
14th Mar 20246:07 pmRNSTransaction in Own Shares
14th Mar 20245:02 pmRNSDirector/PDMR Shareholding
13th Mar 20246:20 pmRNSTransaction in Own Shares
13th Mar 20244:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:06 pmRNSTransaction in Own Shares
12th Mar 202411:00 amRNSIssuance of subordinated unsecured notes
11th Mar 20245:56 pmRNSTransaction in Own Shares
8th Mar 20246:19 pmRNSTransaction in Own Shares
7th Mar 20246:05 pmRNSTransaction in Own Shares
6th Mar 20245:57 pmRNSTransaction in Own Shares
5th Mar 20245:48 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
4th Mar 20243:30 pmRNSIssuance of senior unsecured notes
1st Mar 20246:02 pmRNSTransaction in Own Shares
29th Feb 20245:52 pmRNSTransaction in Own Shares
29th Feb 20244:31 pmRNSDirector/PDMR Shareholding
29th Feb 20244:30 pmRNSTotal Voting Rights
28th Feb 20245:55 pmRNSTransaction in Own Shares
28th Feb 202411:01 amRNSDirector/PDMR Shareholding
28th Feb 202411:00 amRNSOverseas Regulatory Announcement - Grant of Awards
27th Feb 20245:56 pmRNSTransaction in Own Shares
26th Feb 20245:50 pmRNSTransaction in Own Shares
23rd Feb 20246:05 pmRNSTransaction in Own Shares
23rd Feb 20244:35 pmRNSDocuments available at NSM
23rd Feb 20244:20 pmRNSPublication of base prospectus supplement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.